# A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men

> **NCT05742919** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 24 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** NNC0194-0499
- **DRUG:** NNC0194-0499
- **DRUG:** NC0194-0499

## Key facts

- **NCT ID:** NCT05742919
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-16
- **Primary completion:** 2023-06-13
- **Final completion:** 2023-06-13
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05742919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05742919, "A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05742919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*